Materiały źródłowe

• #1 Clinical Overview of Anthrax | Anthrax | CDC

  https://www.cdc.gov/anthrax/hcp/clinical-overview/index.html

  Patients with serious cases of anthrax require hospitalization. They may require aggressive treatment and supportive care, including continuous fluid drainage and mechanical ventilation. […] Anthrax vaccine is also recommended for unvaccinated people of all ages who have been exposed to anthrax. These people should get 3 doses of anthrax vaccine together with recommended antibiotic drugs. […] Antibiotics can be used for post-exposure prophylaxis (PEP) to prevent anthrax from developing in people who have been exposed but have not developed symptoms. All types of anthrax infection can be treated with antibiotics. […] Without treatment, up to 20% of people with cutaneous anthrax die. With appropriate antibiotic treatment, almost all patients with cutaneous anthrax survive. […] Without treatment, inhalation anthrax is almost always fatal. However, with aggressive treatment, about 55 percent of patients survive.

• #1 Anthrax – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/anthrax/diagnosis-treatment/drc-20356209

  The standard treatment for anthrax is use of antibiotics, and in some cases antitoxin. The specific antibiotic chosen will depend on a range of factors, including if theres a need to treat many people. Which single antibiotic or combination of antibiotics, and the length of treatment, will be most effective for you depends on how you were infected with anthrax, the strain of anthrax, your age, your overall health and other concerns. Treatment is most effective when started as soon as possible. […] Since the 2001 attacks in the United States, researchers have developed antitoxin therapies raxibacumab and obiltoxaximab for inhalation anthrax. Instead of going after the bacteria that causes the disease, these medications help eliminate the toxins caused by the infection. Anthrax immunoglobulin also may be used to neutralize the toxins. These medications are given in addition to antibiotics and are available to doctors through the U.S. Centers for Disease Control and Prevention.

• #1 Treatment and prophylaxis – Anthrax in Humans and Animals – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK310491/

  Penicillin G is still the drug of choice in the therapy of naturally-occurring anthrax in most parts of the world. […] In patients exhibiting signs of systemic involvement, such as with inhalational or gastrointestinal anthrax, meningoencephalitis, sepsis, or cutaneous anthrax with extensive oedema, antibiotics should be given intravenously. […] The recommended procedure for treating animals showing clinical illness in which anthrax is thought to be the likely or possible cause is immediate intravenous administration of sodium benzylpenicillin as directed by the manufacturer’s instructions. […] The possibility that subinhibitory concentrations of penicillins may induce β-lactamase and the importance of using adequate doses of penicillin when this is chosen for treatment is covered in section 7.1.2.

• #1 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  With doxycycline, a loading regimen should be used (200 mg PO/IV every 12 hours for 72 hours). In severely ill patients, 200 mg IV/PO every 12 hours may be continued (without toxicity) for the duration of therapy. Oral doxycycline and quinolones have excellent bioavailability; the same blood/tissue levels are obtained with PO and IV therapy. Use any quinolone in patients who are unable to take penicillin or doxycycline. […] The preferred agent used to treat nonbioterrorist anthrax is penicillin. Penicillin is the preferred agent to treat inhalational anthrax and anthrax meningitis. Use meningeal doses for inhalational anthrax because meningitis is often also present. […] For bioterrorist anthrax, use any quinolone or doxycycline for 1-2 weeks. Clindamycin may be added for its anti-exotoxin effect. Use doxycycline or any quinolone (eg, ciprofloxacin, levofloxacin) for postexposure prophylaxis (PEP) to prevent inhalational anthrax. PEP to prevent inhalational anthrax should be continued for 60 days.

• #1 Anthrax Medication: Antibiotics, Other, Corticosteroids, Antidotes, Other, Vaccines

  https://emedicine.medscape.com/article/212127-medication

  Before October 2001, the first-line treatment of anthrax infection and prophylaxis was penicillin; however, this is not the case for bioterrorism-related cases because of the concern for genetically engineered penicillin-resistant anthrax strains. The Centers for Disease Control and Prevention (CDC) recommends ciprofloxacin or doxycycline. Doxycycline should not be used in suspected meningitis because it has poor penetration of the central nervous system. […] Individuals who are pregnant or breastfeeding can use amoxicillin. Resistance exists to third-generation cephalosporins, trimethoprim, and sulfisoxazole. For patients with severe anthrax, therapy with corticosteroids and intravenous antibiotics is recommended. […] Raxibacumab, a monoclonal antibody directed at the protective antigen of Bacillus anthracis, is available from the CDC for treatment of inhalational anthrax in adults and children. It is used as part of a combination regimen with appropriate antibiotic drugs. It is also approved for prophylaxis of inhalational anthrax when alternative therapies are not available or not appropriate.

• #1 Human Anthrax: Update of the Diagnosis and Treatment

  https://www.mdpi.com/2075-4418/13/6/1056

  In severe cases such as inhalational or gastrointestinal anthrax, meningoencephalitis, sepsis or cutaneous anthrax with extensive edema, antibiotics should be administered intravenously; when the fever has subsided to normal, antibiotic therapy may be switched to oral. […] The recommended antibiotic regimens in adult cases are as follows: procaine penicillin G, 0.6–1.2 M units intramuscularly every 12–24 h; amoxicillin 500 mg orally every 6–8 h; doxycycline 100 mg intravenously or orally every 12 h; ciprofloxacin 200–400 mg intravenously every 12 h, followed by 500–750 mg orally every 12 h. […] Ciprofloxacin and doxycycline are considered to be the first-choice agents in cases of biological weapon or bio-terrorism-related anthrax, and are prescribed in the following regimens: ciprofloxacin 200–400 mg intravenously every 12 h, followed by 500–750 mg orally every 12 h; doxycycline 100 mg intravenously or orally every 12 h with the treatment duration of 42–60 days.

• #1 Human Anthrax: Update of the Diagnosis and Treatment

  https://www.mdpi.com/2075-4418/13/6/1056

  Anthrax is one of the most important zoonotic diseases which primarily infects herbivores and occasionally humans. […] With regards to treatment, human isolates are generally susceptible to most antibiotics with penicillin G and amoxicillin as the first choice, and ciprofloxacin and doxycycline serving as alternatives. A combination of one or more antibiotics is suggested in systemic anthrax. […] Currently, antibiotic therapy is still considered the main option for anthrax treatment. However, the approach to anthrax treatment differs from other bacterial infections due to such features as toxin production, the antibiotic resistance problem and high frequency of meningitis occurrence. […] Thus, in naturally occurring anthrax cases, penicillin G and amoxicillin are the first-choice drugs while doxycycline and ciprofloxacin are the alternative agents, in a treatment scheme with a duration of 5–7 days for mild and uncomplicated cutaneous anthrax cases, and 10–14 days for complicated cutaneous and systemic anthrax cases.

• #1 Human Anthrax: Update of the Diagnosis and Treatment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10046981/

  Thus, in naturally occurring anthrax cases, penicillin G and amoxicillin are the first-choice drugs while doxycycline and ciprofloxacin are the alternative agents, in a treatment scheme with a duration of 5-7 days for mild and uncomplicated cutaneous anthrax cases, and 10-14 days for complicated cutaneous and systemic anthrax cases. […] In severe cases such as inhalational or gastrointestinal anthrax, meningoencephalitis, sepsis or cutaneous anthrax with extensive edema, antibiotics should be administered intravenously; when the fever has subsided to normal, antibiotic therapy may be switched to oral. […] In inhalation anthrax, patients may require mechanical ventilation due to respiratory failure caused by reaccumulating pleural effusions. […] A combination of antibiotics is preferred with one of them being able to penetrate to the central nervous system. […] In addition to antibiotic therapy, specific antitoxin serum for anthrax may be used in injectional anthrax and systemic anthrax.

• #1 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  Compared with monotherapy, antimicrobial combination therapy is more likely to result in a cure; combined bactericidal and protein synthesis inhibitor agents may be beneficial. […] Treatment for anthrax meningitis should include at least 3 antimicrobial drugs with activity against B anthracis, at least 1 of which should have bactericidal activity, and at least 1 of which should be a protein synthesis inhibitor. […] For patients suspected to have systemic anthrax, antitoxin should be added to combination antimicrobial drug treatment. […] Uncomplicated cutaneous anthrax can be treated with a single oral agent; fluoroquinolones (ciprofloxacin, levofloxacin, and moxifloxacin) and doxycycline are equivalent first-line drugs. […] All patients with suspected systemic anthrax should be begun immediately on IV antibiotics with co-administration of an antitoxin (raxibacumab or anthrax IgG) and should receive aggressive supportive care. All patients with suspected systemic illness should be admitted to inpatient for treatment. Early diagnosis and clinical suspicion are critical to improving outcomes.

• #1 Anthrax – Infections – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/infections/bacterial-infections-gram-positive-bacteria/anthrax

  Antibiotics and the vaccine must be given soon after exposure to reduce the risk of severe illness or death. […] The longer anthrax treatment is delayed, the greater the risk of death. Thus, treatment is usually started as soon as doctors suspect that people have anthrax. […] Skin anthrax (cutaneous anthrax) is treated with the antibiotics ciprofloxacin, levofloxacin, moxifloxacin, or doxycycline given by mouth for 7 to 10 days. Antibiotics are taken for 60 days if it is possible spores were inhaled or a bioattack is suspected. Children and pregnant women may receive different antibiotics for a different length of time. […] Inhalation, gastrointestinal, and other anthrax infections including severe skin anthrax are treated with a combination of three antibiotics given by vein (intravenously). Once the intravenous antibiotics are done, people are given an antibiotic by mouth for 60 days to kill any remaining spores in the lungs.

• #1 Cutaneous anthrax | MSF Medical Guidelines

  https://medicalguidelines.msf.org/en/viewport/CG/english/cutaneous-anthrax-16689676.html

  Uncomplicated cutaneous anthrax […] Antibiotic treatment for 7 to 10 days: First-line antibiotics: ciprofloxacin PO (including in pregnant or breastfeeding women and children) Children: 15 mg/kg (max. 500 mg) 2 times daily Adults: 500 mg 2 times daily or doxycycline PO (except in pregnant or breastfeeding women) Children under 45 kg: 2 to 2.2 mg/kg (max. 100 mg) 2 times daily Children 45 kg and over and adults: 100 mg 2 times daily […] Severe cutaneous anthrax […] Combined antibiotic treatment for 14 days: First-line: ciprofloxacin IV infusion over 60 minutes […] + clindamycin IV infusion over 30 minutes […] Change to oral treatment as soon as possible to complete 14 days of treatment with ciprofloxacin + clindamycin or amoxicillin + clindamycin as for uncomplicated cutaneous anthrax.

• #1

  https://dermnetnz.org/topics/anthrax

  Cutaneous anthrax is treated with antibiotics. Treatment must be started straight away to reduce the chance of the anthrax spreading from the initial skin lesion. […] Traditionally, treatment has been with intravenous or intramuscular penicillin for 710 days. However, for uncomplicated cutaneous anthrax, an oral tetracycline, especially doxycycline, is given in an outpatient setting. It is also suitable for those allergic to penicillin. […] With recent concerns that B. anthracis in the setting of bioterrorism may be resistant to penicillin and tetracycline, a quinolone such as ciprofloxacin is becoming the antibiotic of choice. It is particularly used for inhaled anthrax infection. Initially, it should be given intravenously, and then continued orally for up to 60 days. […] In some cases, it is necessary to surgically scrape off the black eschar from the anthrax ulcer. It is essential that this is done with antibiotic cover as interfering with the wound could encourage the spread of the bacteria. If the eventual scar is unsightly, a plastic surgeon may be able to improve its appearance later. […] A newer treatment for inhalational anthrax is the monoclonal antibody raxibacumab. It is used as part of combination therapy with appropriate antibiotic agents.

• #1 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  Antimicrobial therapy renders lesions culture-negative within hours, but the lethal effects of anthrax are related to the effects of the organism’s toxin. Patients with septic and hemorrhagic shock, which is the final common pathway for end-stage anthrax infection, should be admitted to the intensive care unit for hemodynamic monitoring and management. In addition, progressive respiratory insufficiency may necessitate the use of ventilatory support. […] Despite early treatment, persons infected with inhalational, gastrointestinal, or meningeal anthrax have a very poor prognosis. Although prophylaxis and vaccinations confer almost complete protection, adequately providing immunity to a potentially exposed community is extremely difficult. […] The CDC has issued updated guidelines on anthrax postexposure prophylaxis (PEP) and treatment in nonpregnant and pregnant adults. Recommendations include the following: All individuals exposed to aerosolized B anthracis spores should receive a full 60 days of PEP antimicrobial drugs, regardless of their vaccination status.

• #1 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  In patients with suspected or confirmed anthrax meningitis, if not already done, a lumbar puncture should be performed for CSF analysis. Immediate antibiotics are warranted, and lumbar puncture should never delay therapy. Two bactericidal agents plus a protein synthesis inhibitor are indicated. All must be dosed for CSF penetration. […] Anticipate a therapy duration of at least three weeks or until clinical improvement, whichever comes last, as clinical improvement may take several weeks. Thereafter, patients should complete a 60-day course of antibiotics with oral monotherapy to prevent relapse involving dormant endospores. Oral antibiotic should be dosed according to guidelines for postexposure prophylaxis.

• #1 Clinical Overview of Anthrax | Anthrax | CDC

  https://www.cdc.gov/anthrax/hcp/clinical-overview/index.html

  Without treatment, more than half of patients with gastrointestinal anthrax die. However, with proper treatment, 60 percent of patients survive. […] After anthrax toxins, which are released when anthrax spores are activated, have been released in the body, one possible treatment is anthrax antitoxin. Doctors must use antitoxin together with other treatment options, including antibiotics. Currently, there are a few types of antitoxins that can be used for treating anthrax.

• #1 Anthrax – Causes, Symptoms, Treatment, Diagnosis – MedBroadcast.com

  https://medbroadcast.com/condition/getcondition/anthrax

  Anthrax is prevented with immunization and antibiotic treatment for those people who have been exposed to anthrax. […] Cutaneous anthrax is usually treated with either fluoroquinolone antibiotics (e.g., ciprofloxacin*, moxifloxacin, levofloxacin), or doxycycline for 7 to 10 days for naturally-acquired infections. […] Pulmonary anthrax is usually treated with a dual combination of injected (intravenous) antibiotics: either ciprofloxacin with clindamycin, or ciprofloxacin with linezolid.

• #1 Human Anthrax: Update of the Diagnosis and Treatment

  https://www.mdpi.com/2075-4418/13/6/1056

  In severe and complicated cases antibiotics should be administered intravenously. […] In inhalation anthrax, patients may require mechanical ventilation due to respiratory failure caused by reaccumulating pleural effusions. […] A combination of antibiotics is preferred with one of them being able to penetrate to the central nervous system. […] The duration of treatment for anthrax meningoencephalitis should be carried out for at least two weeks or until the clinical stability of the patient’s condition. […] In addition to antibiotic therapy, specific antitoxin serum for anthrax may be used in injectional anthrax and systemic anthrax.

• #1 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  Raxibacumab is a human IgG1 gamma monoclonal antibody directed at the protective antigen of Bacillus anthracis. It is produced by recombinant DNA technology in a murine cell expression system. This agent was approved by the FDA in December 2012 for treatment of inhalational anthrax or for prevention when alternative therapies are not available or appropriate. It is used as part of a combination regimen with appropriate antibiotic drugs. […] Human anthrax immune globulin (Anthrasil) is indicated for treatment of inhalational anthrax in adults and children in combination with antibiotic therapy. […] The indication for anthrax vaccine adsorbed (BioThrax) was expanded in November 2015 to include postexposure use following suspected or confirmed B anthracis exposure in combination with antimicrobial therapy. It was originally approved for pre-exposure prophylaxis in high-risk individuals.

• #1 ANTHIM® obiltoxaximab | Ihalational anthrax treatment and prevention

  https://anthim.com/treatment-and-prevention.html

  Hospitalization is warranted for all patients with suspected inhalational anthrax. The CDC guidance for treatment is summarized here. Antibiotics target Bacillus anthracis but have no direct effect on toxins that have been released, or the systemic damage they cause. Antitoxins are a class of FDA-approved drugs that complement antibiotics for anthrax treatment by preventing toxins from entering cells and exerting their deleterious effects. […] ANTHIM (obiltoxaximab) is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs. ANTHIM is indicated for prophylaxis of inhalational anthrax due to B. anthracis when alternative therapies are not available or are not appropriate. […] ANTHIM binds to the protective antigen (PA) component of B. anthracis toxin; it does not have direct antibacterial activity. ANTHIM is not expected to cross the blood-brain barrier and does not prevent or treat meningitis. ANTHIM should be used in combination with appropriate antibacterial drugs.

• #1 Anthrax Treatment Options: Antibiotics, Antitoxins, And Supportive Care – Klarity Health Library

  https://my.klarity.health/anthrax-treatment-options-antibiotics-antitoxins-and-supportive-care/

  Treatment may be different if it is suspected that the anthrax infection is related to a biological weapon or bio-terrorism, the course of antibiotics would then be administered for up to 60 days to ensure that the bacteria that causes anthrax is destroyed. […] Antitoxins focus on neutralizing the toxins released by the Bacillus anthracis bacteria, and they are generally given alongside antibiotics. The two main antitoxins used in anthrax treatment are Raxibacumab and Obiltoxaximab, both of which are monoclonal antibodies. […] By mitigating toxin effects, antitoxins reduce systemic damage, prevent organ failure, and improve survival outcomes. Administering antitoxins early in the course of infection significantly enhances their effectiveness, as delayed use may allow toxins to irreversibly damage tissues and organs.

• #1 Anthrax – Infectious Diseases – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/infectious-diseases/gram-positive-bacilli/anthrax

  Raxibacumab and obiltoxaximab are monoclonal antibodies that bind to the protective antigen component of B. anthracis toxin and can be used in combination with antibiotics to treat inhalation anthrax. […] IV anthrax human immune globulin prepared from the plasma of donors who have been vaccinated against anthrax can be used in combination with antibiotics to treat inhalation anthrax. […] Drug resistance is a concern. […] Patients with inhalation anthrax require supportive care and sometimes mechanical ventilation. Prompt and continuous pleural fluid drainage by chest tube is critical.

• #1 Most effective anthrax treatment: Rapid diagnosis, antibiotics and lung drainage, VA-Stanford study finds | News Center

  https://med.stanford.edu/news/all-news/2006/02/most-effective-anthrax-treatment-rapid-diagnosis-antibiotics-and-lung-drainage-va-stanford-study-finds.html

  The study findings, published in the Feb. 21 issue of the Annals of Internal Medicine, underscore the importance of detecting anthrax early, educating medical personnel about its symptoms and treatment and ensuring efficient distribution systems that can deliver antibiotics to patients within hours of a bioterrorist attack. […] 'Even with our modern intensive care, once you’ve reached the advanced stage of this disease, you’re probably going to die. That’s why it’s crucial to start antibiotics within the first few days,’ said lead author Jon-Erik Holty, MD, a fellow in pulmonary and critical-care medicine at Stanford, who did the research during a fellowship in health services research at the VA Palo Alto Health Care System. […] Timely antibiotic treatment was the key to patients’ survival. When antibiotics were begun within two days of initial symptoms, approximately 20 percent of patients died. When treatment was begun at four days, mortality was about 58 percent, and at six days it was nearly 80 percent. Multi-drug regimens were found to be more effective than single-drug regimens. And among all the anthrax patients who survived, 80 percent had fluid drained from around their lungs, a procedure known as pleural fluid drainage.

• #1 Anthrax – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/anthrax/diagnosis-treatment/drc-20356209

  Some cases of injection anthrax have been successfully treated with surgical removal of infected tissue. […] Although some cases of anthrax respond to antibiotics, advanced inhalation anthrax may not. By the later stages of the disease, the bacteria have often produced more toxins than drugs can eliminate. […] Along with antibiotics, people with anthrax may be treated with intensive supportive care including ventilators, fluids and medicines to tighten blood vessels and raise blood pressure (vasopressors).

• #1 Anthrax – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/anthrax/

  Mortality is high but swift treatment with antibiotics (e.g., fluoroquinolones, linezolid, meropenem) can increase survival. […] Treatment of anthrax Type of treatment Cutaneous anthrax Inhalation anthrax Gastrointestinal anthrax Antibacterial Without systemic spread Oral monotherapy with either a fluoroquinolone (e.g., ciprofloxacin, levofloxacin, or moxifloxacin) or doxycycline. […] With systemic spread Antitoxin therapy: raxibacumab, obiltoxaximab, or anthrax immunoglobulin. […] Combination of IV antibiotics Patients without meningitis: ciprofloxacin and linezolid. […] Patients with (confirmed or suspected) meningitis: ciprofloxacin, linezolid, and meropenem. […] General fluid resuscitation in case of shock. […] Systemic glucocorticoids are indicated in the following situations: Meningitis, Shock that does not respond to fluid resuscitation and vasopressors, Severe edema of the head and neck.

• #1 Rational corticosteroids administration and antibiotic treatment is key to managing cutaneous anthrax | BMC Infectious Diseases | Full Text

  https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09922-9

  According to the recommendations of the World Health Organization (WHO), penicillin G is the preferred drug for treating anthrax. […] However, studies have shown that although Bacillus anthracis is highly susceptible to penicillin in laboratories, patients with high levels of the bacteria, such as those with inhalational anthrax, may develop penicillin resistance due to the production of beta-lactamase. […] Administration of corticosteroids might help reduce inflammatory edema in patients with severe toxemia symptoms or malignant edema. […] Our results indicated that administering corticosteroids to patients with moderate-to-severe oedema and severe systemic symptoms of infectious toxicity may accelerate the regression of edema at the site of infection, leading to a shorter hospital stay for the patient. […] When selecting an antibiotic regimen, the potential for -lactamase production and antibiotic resistance among clinical isolates should be considered. Piperacillin-tazobactam may be a viable option for initial treatment.

• #1 USAMRIID: Experimental Treatment with Enzyme Protects Mice from Lethal Anthrax Infection

  https://usamriid.health.mil/index.cfm/media/press_releases/2021/experimental_enzyme_treatment

  Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with the deadly disease. […] Their findings suggest a potential therapeutic strategy for treating multidrug-resistant strains of anthrax, and could lead to new treatments for other bacterial infections. […] Public health officials have become increasingly concerned about strains of anthrax that appear to be resistant to treatment with known antibiotics. […] One promising avenue is to make the bacterium more susceptible to the innate immune system—the human body’s first line of defense against a pathogenic „invader.” […] Enzymes known as capsular depolymerases, which are naturally produced by several classes of bacteria, have emerged as a potential new line of antivirulence agents.

• #1 Anthrax – Wikipedia

  https://en.wikipedia.org/wiki/Anthrax

  Antibiotics, antitoxin. […] If infection occurs, treatment is with antibiotics and possibly antitoxin. […] The type and number of antibiotics used depend on the type of infection. […] Antitoxin is recommended for those with widespread infection. […] Early antibiotic treatment of anthrax is essential; delay significantly lessens chances for survival. Treatment for anthrax infection and other bacterial infections includes large doses of intravenous and oral antibiotics, such as fluoroquinolones (ciprofloxacin), doxycycline, erythromycin, vancomycin, or penicillin. […] In possible cases of pulmonary anthrax, early antibiotic prophylaxis treatment is crucial to prevent possible death. […] Raxibacumab is a monoclonal antibody that neutralizes toxins produced by Bacillus anthracis. […] Obiltoxaximab is approved to treat inhalational anthrax in conjunction with appropriate antibacterial drugs, and for prevention when alternative therapies are not available or appropriate. […] Treatment of multi-drug resistant, antibody- or vaccine-resistant Anthrax is also possible. […] The CapD enzyme removes the poly-D-glutamate (PDGA) capsular material from the bacteria, rendering it susceptible to the innate immune responses.

• #1 Anthrax – Symptoms & causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/anthrax/symptoms-causes/syc-20356203

  Signs and symptoms, which depend on how you’re infected, can include skin sores, vomiting and shock. Prompt treatment with antibiotics can cure most anthrax infections. Inhaled anthrax is more difficult to treat and can be fatal. […] To prevent infection after being exposed to anthrax spores, the Centers for Disease Control and Prevention recommends: A 60-day treatment with antibiotics ciprofloxacin, doxycycline and levofloxacin are approved for adults and children. […] In some cases, treatment with monoclonal antibodies raxibacumab and obiltoxaximab.

• #1

  https://www.ncid.sg/Health-Professionals/Diseases-and-Conditions/Pages/Anthrax.aspx

  Children: IV ciprofloxacin 20-30 mg/kg/day bd (not to exceed 1g/day) or IV doxycycline 2.2 mg/kg 12 hourly for patients 45 kg; adult dose if 45 kg plus one or two additional agents (as for adults above). Continue antibiotic treatment for 60 days. […] Prophylaxis should be provided to all persons who may have been directly exposed to the spores. It is critical to administer chemoprophylactic antibiotics as soon as possible after potential exposure. Oral ciprofloxacin 500 mg bd is the recommended first line medication in a situation with anthrax as the presumptive agent. Alternatives: oral doxycycline 100 mg bd or amoxicillin 500 mg 8 hourly if the strain is sensitive. Oral antibiotic prophylaxis should be continued for at least 60 days. If vaccine is available, all exposed persons should be vaccinated with three doses of anthrax vaccine (days 0, 14, 28).

• #1 Anthrax (Bacillus Anthracis): Symptoms & Causes

  https://my.clevelandclinic.org/health/diseases/10853-anthrax

  If you think you’ve been exposed to anthrax, call your healthcare provider to start antibiotics or other therapies immediately. Untreated anthrax can be deadly. Fast treatment can prevent severe infection and life-threatening symptoms, improving your odds of a full recovery. […] Most people infected with anthrax recover after receiving prompt treatment with antibiotics or other therapies.

• #2 Treatment and prophylaxis – Anthrax in Humans and Animals – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK310491/

  Antibiotics are only effective against anthrax if administered early enough in the course of the infection. […] The use of serum therapy for treatment of anthrax predates by several decades the realization that death was caused by toxin action. […] The swelling seen in an anthrax infection is caused by the action of oedema toxin, and inflammation is fairly minimal. […] The suggestion given in the third edition of these guidelines (1998) that penicillin may be replaced by chloramphenicol for patients who are hypersensitive to penicillin has now been withdrawn. […] Recurrence of disease on termination of treatment is very rare, but convalescent cases should remain under observation for at least a week after treatment has been discontinued.

• #2 Anthrax: Causes, treatments, and risks

  https://www.medicalnewstoday.com/articles/37557

  Treatment is with antibiotics, which must be started soon after infection. […] Anthrax must be treated as quickly as possible, before the levels of toxins and harmful bacteria within the body become too high for drugs to eliminate. […] The standard treatment for anthrax is with antibiotics and antitoxins. The type of antibiotics will depend on how the infection occurred, the individuals age and medical history. […] Antitoxin therapies are currently being developed that target the toxins released by B. anthracis, rather than the bacteria themselves. […] Recently, surgical removal of infected tissue has been used successfully to treat injection anthrax. […] In 2013, a team of researchers discovered a new chemical compound from the sea that could be used to treat anthrax and MRSA.

• #2 Human Anthrax: Update of the Diagnosis and Treatment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10046981/

  Anthrax is one of the most important zoonotic diseases which primarily infects herbivores and occasionally humans. […] With regards to treatment, human isolates are generally susceptible to most antibiotics with penicillin G and amoxicillin as the first choice, and ciprofloxacin and doxycycline serving as alternatives. A combination of one or more antibiotics is suggested in systemic anthrax. […] Currently, antibiotic therapy is still considered the main option for anthrax treatment. However, the approach to anthrax treatment differs from other bacterial infections due to such features as toxin production, the antibiotic resistance problem and high frequency of meningitis occurrence. In vitro, B. anthracis clinical isolates are susceptible to various antibiotics including penicillin, aminoglycosides, macrolides, quinolones, carbapenems, tetracyclines, vancomycin, clindamycin, rifampicin, cefazolin and linezolid. The recommendations for antibiotic prescription differ depending on the site and severity of the disease.

• #2 Human Anthrax: Update of the Diagnosis and Treatment

  https://www.mdpi.com/2075-4418/13/6/1056

  Anthrax is one of the most important zoonotic diseases which primarily infects herbivores and occasionally humans. […] With regards to treatment, human isolates are generally susceptible to most antibiotics with penicillin G and amoxicillin as the first choice, and ciprofloxacin and doxycycline serving as alternatives. A combination of one or more antibiotics is suggested in systemic anthrax. […] Currently, antibiotic therapy is still considered the main option for anthrax treatment. However, the approach to anthrax treatment differs from other bacterial infections due to such features as toxin production, the antibiotic resistance problem and high frequency of meningitis occurrence. […] Thus, in naturally occurring anthrax cases, penicillin G and amoxicillin are the first-choice drugs while doxycycline and ciprofloxacin are the alternative agents, in a treatment scheme with a duration of 5–7 days for mild and uncomplicated cutaneous anthrax cases, and 10–14 days for complicated cutaneous and systemic anthrax cases.

• #2 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  With doxycycline, a loading regimen should be used (200 mg PO/IV every 12 hours for 72 hours). In severely ill patients, 200 mg IV/PO every 12 hours may be continued (without toxicity) for the duration of therapy. Oral doxycycline and quinolones have excellent bioavailability; the same blood/tissue levels are obtained with PO and IV therapy. Use any quinolone in patients who are unable to take penicillin or doxycycline. […] The preferred agent used to treat nonbioterrorist anthrax is penicillin. Penicillin is the preferred agent to treat inhalational anthrax and anthrax meningitis. Use meningeal doses for inhalational anthrax because meningitis is often also present. […] For bioterrorist anthrax, use any quinolone or doxycycline for 1-2 weeks. Clindamycin may be added for its anti-exotoxin effect. Use doxycycline or any quinolone (eg, ciprofloxacin, levofloxacin) for postexposure prophylaxis (PEP) to prevent inhalational anthrax. PEP to prevent inhalational anthrax should be continued for 60 days.

• #2 Human Anthrax: Update of the Diagnosis and Treatment

  https://www.mdpi.com/2075-4418/13/6/1056

  In severe cases such as inhalational or gastrointestinal anthrax, meningoencephalitis, sepsis or cutaneous anthrax with extensive edema, antibiotics should be administered intravenously; when the fever has subsided to normal, antibiotic therapy may be switched to oral. […] The recommended antibiotic regimens in adult cases are as follows: procaine penicillin G, 0.6–1.2 M units intramuscularly every 12–24 h; amoxicillin 500 mg orally every 6–8 h; doxycycline 100 mg intravenously or orally every 12 h; ciprofloxacin 200–400 mg intravenously every 12 h, followed by 500–750 mg orally every 12 h. […] Ciprofloxacin and doxycycline are considered to be the first-choice agents in cases of biological weapon or bio-terrorism-related anthrax, and are prescribed in the following regimens: ciprofloxacin 200–400 mg intravenously every 12 h, followed by 500–750 mg orally every 12 h; doxycycline 100 mg intravenously or orally every 12 h with the treatment duration of 42–60 days.

• #2 Human Anthrax: Update of the Diagnosis and Treatment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10046981/

  Thus, in naturally occurring anthrax cases, penicillin G and amoxicillin are the first-choice drugs while doxycycline and ciprofloxacin are the alternative agents, in a treatment scheme with a duration of 5-7 days for mild and uncomplicated cutaneous anthrax cases, and 10-14 days for complicated cutaneous and systemic anthrax cases. […] In severe cases such as inhalational or gastrointestinal anthrax, meningoencephalitis, sepsis or cutaneous anthrax with extensive edema, antibiotics should be administered intravenously; when the fever has subsided to normal, antibiotic therapy may be switched to oral. […] In inhalation anthrax, patients may require mechanical ventilation due to respiratory failure caused by reaccumulating pleural effusions. […] A combination of antibiotics is preferred with one of them being able to penetrate to the central nervous system. […] In addition to antibiotic therapy, specific antitoxin serum for anthrax may be used in injectional anthrax and systemic anthrax.

• #2 Anthrax – including symptoms, treatment and prevention | SA Health

  https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/conditions/infectious+diseases/anthrax/anthrax+-+including+symptoms+treatment+and+prevention

  Treatment for anthrax is essential, particularly for inhalational anthrax. In some situations preventative antibiotics may also be given to people who are suspected to have been exposed to anthrax spores. […] Up to 20% of untreated people may die. Deaths from cutaneous anthrax are rare with appropriate antibiotic treatment. […] Up to 60% of people with intestinal anthrax will die without treatment.

• #2 Anthrax | Paramedic Kardex

  https://www.paramedickardex.com/copy-of-dico-handbook

  Treatment for anthrax meningitis should include at least 3 antimicrobial drugs with activity against B anthracis, at least 1 of which should have bactericidal activity, and at least 1 of which should be a protein synthesis inhibitor […] Uncomplicated cutaneous anthrax can be treated with a single oral agent; fluoroquinolones (ciprofloxacin, levofloxacin, and moxifloxacin) and doxycycline are equivalent first-line drugs.

• #2 Cutaneous anthrax | MSF Medical Guidelines

  https://medicalguidelines.msf.org/en/viewport/CG/english/cutaneous-anthrax-16689676.html

  Uncomplicated cutaneous anthrax […] Antibiotic treatment for 7 to 10 days: First-line antibiotics: ciprofloxacin PO (including in pregnant or breastfeeding women and children) Children: 15 mg/kg (max. 500 mg) 2 times daily Adults: 500 mg 2 times daily or doxycycline PO (except in pregnant or breastfeeding women) Children under 45 kg: 2 to 2.2 mg/kg (max. 100 mg) 2 times daily Children 45 kg and over and adults: 100 mg 2 times daily […] Severe cutaneous anthrax […] Combined antibiotic treatment for 14 days: First-line: ciprofloxacin IV infusion over 60 minutes […] + clindamycin IV infusion over 30 minutes […] Change to oral treatment as soon as possible to complete 14 days of treatment with ciprofloxacin + clindamycin or amoxicillin + clindamycin as for uncomplicated cutaneous anthrax.

• #2 Anthrax | Doctor

  https://patient.info/doctor/anthrax-pro

  Cutaneous anthrax should be treated with either ciprofloxacin (unlicensed indication) or doxycycline (unlicensed indication) for seven days. Treatment may be switched to amoxicillin if the infecting strain is susceptible. Treatment may need to be extended to 60 days if exposure is due to aerosol. A combination of antibacterials for 14 days is recommended for cutaneous anthrax with systemic features, extensive oedema, or lesions of the head or neck. […] Management is multidisciplinary with timely surgical debridement to remove the primary source of toxin, with a combination of antibacterials. […] Anthrax is treatable if antibiotics are administered promptly and continued for 60 days. However, if treatment is delayed or administered improperly, the patient’s chances of survival are drastically decreased. […] Cutaneous anthrax is readily treatable with antibiotics if diagnosed early. […] Mortality is often high for inhalation and gastrointestinal anthrax because of delayed diagnosis and also the lack of readily available treatment in developing countries.

• #2 Clinical Overview of Anthrax | Anthrax | CDC

  https://www.cdc.gov/anthrax/hcp/clinical-overview/index.html

  Without treatment, more than half of patients with gastrointestinal anthrax die. However, with proper treatment, 60 percent of patients survive. […] After anthrax toxins, which are released when anthrax spores are activated, have been released in the body, one possible treatment is anthrax antitoxin. Doctors must use antitoxin together with other treatment options, including antibiotics. Currently, there are a few types of antitoxins that can be used for treating anthrax.

• #2 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  Compared with monotherapy, antimicrobial combination therapy is more likely to result in a cure; combined bactericidal and protein synthesis inhibitor agents may be beneficial. […] Treatment for anthrax meningitis should include at least 3 antimicrobial drugs with activity against B anthracis, at least 1 of which should have bactericidal activity, and at least 1 of which should be a protein synthesis inhibitor. […] For patients suspected to have systemic anthrax, antitoxin should be added to combination antimicrobial drug treatment. […] Uncomplicated cutaneous anthrax can be treated with a single oral agent; fluoroquinolones (ciprofloxacin, levofloxacin, and moxifloxacin) and doxycycline are equivalent first-line drugs. […] All patients with suspected systemic anthrax should be begun immediately on IV antibiotics with co-administration of an antitoxin (raxibacumab or anthrax IgG) and should receive aggressive supportive care. All patients with suspected systemic illness should be admitted to inpatient for treatment. Early diagnosis and clinical suspicion are critical to improving outcomes.

• #2 Anthrax Medication: Antibiotics, Other, Corticosteroids, Antidotes, Other, Vaccines

  https://emedicine.medscape.com/article/212127-medication

  Before October 2001, the first-line treatment of anthrax infection and prophylaxis was penicillin; however, this is not the case for bioterrorism-related cases because of the concern for genetically engineered penicillin-resistant anthrax strains. The Centers for Disease Control and Prevention (CDC) recommends ciprofloxacin or doxycycline. Doxycycline should not be used in suspected meningitis because it has poor penetration of the central nervous system. […] Individuals who are pregnant or breastfeeding can use amoxicillin. Resistance exists to third-generation cephalosporins, trimethoprim, and sulfisoxazole. For patients with severe anthrax, therapy with corticosteroids and intravenous antibiotics is recommended. […] Raxibacumab, a monoclonal antibody directed at the protective antigen of Bacillus anthracis, is available from the CDC for treatment of inhalational anthrax in adults and children. It is used as part of a combination regimen with appropriate antibiotic drugs. It is also approved for prophylaxis of inhalational anthrax when alternative therapies are not available or not appropriate.

• #2 Anthrax – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/anthrax/

  Mortality is high but swift treatment with antibiotics (e.g., fluoroquinolones, linezolid, meropenem) can increase survival. […] Treatment of anthrax Type of treatment Cutaneous anthrax Inhalation anthrax Gastrointestinal anthrax Antibacterial Without systemic spread Oral monotherapy with either a fluoroquinolone (e.g., ciprofloxacin, levofloxacin, or moxifloxacin) or doxycycline. […] With systemic spread Antitoxin therapy: raxibacumab, obiltoxaximab, or anthrax immunoglobulin. […] Combination of IV antibiotics Patients without meningitis: ciprofloxacin and linezolid. […] Patients with (confirmed or suspected) meningitis: ciprofloxacin, linezolid, and meropenem. […] General fluid resuscitation in case of shock. […] Systemic glucocorticoids are indicated in the following situations: Meningitis, Shock that does not respond to fluid resuscitation and vasopressors, Severe edema of the head and neck.

• #2 Anthrax | Monroe County, MI

  https://www.co.monroe.mi.us/185/Anthrax

  Anthrax is diagnosed by isolating B anthracis from the blood, skin lesions, or respiratory secretions or by measuring specific antibodies in the blood of suspected cases. […] Given the rapid course of symptomatic inhalation anthrax, early antibiotic use is essential – a delay, even in hours, may lesson chances for survival. For those treated with antibiotics and surviving, the risk of recurrence remains for at least 60 days without a course of vaccination. […] Doctors can prescribe effective antibiotics. Usually penicillin is preferred when the organism is found to be susceptible. Erythromycin, tetracycline, ciprofloxacin, doxycycline or chloramphenicol can also be used. Antibiotic regimens commonly recommended for the treatment of sepsis have not been studied extensively in treating humans for inhalation anthrax. However, it is important to note that to be effective, treatment should be initiated early.

• #2 Anthrax – Infectious Diseases – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/infectious-diseases/gram-positive-bacilli/anthrax

  Treatment should be given intravenously for 2 weeks or until the patient is clinically stable, whichever is longer. Once IV combination therapy is completed, therapy should be continued with a single oral antibiotic given for 60 days to prevent relapse resulting from ungerminated spores in the lungs. […] Appropriate antibiotics with bactericidal activity include a fluoroquinolone, a carbapenem, and for penicillin-susceptible strains, penicillin G or ampicillin. […] Appropriate antibiotics that inhibit protein synthesis include Linezolid, Clindamycin, Rifampin, and Chloramphenicol. […] If meningitis is suspected, meropenem should be used with other antibiotics because it has good central nervous system penetration. […] Corticosteroids may be useful for meningitis and severe mediastinal edema but have not been evaluated adequately.

• #2 Human Anthrax: Update of the Diagnosis and Treatment

  https://www.mdpi.com/2075-4418/13/6/1056

  In severe and complicated cases antibiotics should be administered intravenously. […] In inhalation anthrax, patients may require mechanical ventilation due to respiratory failure caused by reaccumulating pleural effusions. […] A combination of antibiotics is preferred with one of them being able to penetrate to the central nervous system. […] The duration of treatment for anthrax meningoencephalitis should be carried out for at least two weeks or until the clinical stability of the patient’s condition. […] In addition to antibiotic therapy, specific antitoxin serum for anthrax may be used in injectional anthrax and systemic anthrax.

• #2 Anthrax – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/anthrax/diagnosis-treatment/drc-20356209

  The standard treatment for anthrax is use of antibiotics, and in some cases antitoxin. The specific antibiotic chosen will depend on a range of factors, including if theres a need to treat many people. Which single antibiotic or combination of antibiotics, and the length of treatment, will be most effective for you depends on how you were infected with anthrax, the strain of anthrax, your age, your overall health and other concerns. Treatment is most effective when started as soon as possible. […] Since the 2001 attacks in the United States, researchers have developed antitoxin therapies raxibacumab and obiltoxaximab for inhalation anthrax. Instead of going after the bacteria that causes the disease, these medications help eliminate the toxins caused by the infection. Anthrax immunoglobulin also may be used to neutralize the toxins. These medications are given in addition to antibiotics and are available to doctors through the U.S. Centers for Disease Control and Prevention.

• #2 Anthrax Treatment & Management: Approach Considerations, Cutaneous Anthrax, Prehospital Care

  https://emedicine.medscape.com/article/212127-treatment

  Raxibacumab is a human IgG1 gamma monoclonal antibody directed at the protective antigen of Bacillus anthracis. It is produced by recombinant DNA technology in a murine cell expression system. This agent was approved by the FDA in December 2012 for treatment of inhalational anthrax or for prevention when alternative therapies are not available or appropriate. It is used as part of a combination regimen with appropriate antibiotic drugs. […] Human anthrax immune globulin (Anthrasil) is indicated for treatment of inhalational anthrax in adults and children in combination with antibiotic therapy. […] The indication for anthrax vaccine adsorbed (BioThrax) was expanded in November 2015 to include postexposure use following suspected or confirmed B anthracis exposure in combination with antimicrobial therapy. It was originally approved for pre-exposure prophylaxis in high-risk individuals.

• #2 Anthrax Medication: Antibiotics, Other, Corticosteroids, Antidotes, Other, Vaccines

  https://emedicine.medscape.com/article/212127-medication

  Human anthrax immune globulin (Anthrasil) is indicated for treatment of inhalational anthrax in adults and children in combination with antibiotic therapy. […] Cases of gastrointestinal and cutaneous anthrax can be treated with ciprofloxacin or doxycycline for 60 days. Penicillin such as amoxicillin or amoxicillin-clavulanate may be used to complete the course if the strain is susceptible. […] Measures to prevent anthrax infection after exposure include vaccination, decontamination, and prophylactic treatment. For people who have been exposed to anthrax but do not have symptoms, 60 days of ciprofloxacin, a tetracycline (including doxycycline), or penicillin is given to reduce the risk or progression of disease due to inhaled anthrax. […] Two vaccines (anthrax vaccine adsorbed [AVA]; AVA adjuvanted) are also available. AVA is indicated for pre-exposure prophylaxis in persons at high risk for exposure and for postexposure prophylaxis following suspected or confirmed B anthracis exposure. AVA adjuvanted is indicated for postexposure prophylaxis.

• #2 Raxibacumab: potential role in the treatment of inhalational anthrax | IDR

  https://www.dovepress.com/raxibacumab-potential-role-in-the-treatment-of-inhalational-anthrax-peer-reviewed-fulltext-article-IDR

  Current therapy guidelines recommend use of antibiotics that are highly effective against Bacillus anthracis, but until recently did not recommend administration of antitoxin therapy. […] Thus, passive immunity in the form of protective antibodies has a role in treatment as well as post-exposure prophylaxis against inhalational anthrax. […] Raxibacumab is a recombinant human immunoglobulin G1 monoclonal antibody that blocks the binding of PA to its cell receptor, thereby inhibiting pore formation and internalization of edema and lethal toxins. […] Raxibacumab does not have any direct antibacterial activity. Therefore, it is advised that its use should be combined with the antibiotics recommended for the treatment of anthrax. […] Raxibacumab is given intravenously as a single dose and its current FDA-approved indications include use as therapy for and prevention against inhalational anthrax.

• #2 Anthrax Treatment Options: Antibiotics, Antitoxins, And Supportive Care – Klarity Health Library

  https://my.klarity.health/anthrax-treatment-options-antibiotics-antitoxins-and-supportive-care/

  Treatment may be different if it is suspected that the anthrax infection is related to a biological weapon or bio-terrorism, the course of antibiotics would then be administered for up to 60 days to ensure that the bacteria that causes anthrax is destroyed. […] Antitoxins focus on neutralizing the toxins released by the Bacillus anthracis bacteria, and they are generally given alongside antibiotics. The two main antitoxins used in anthrax treatment are Raxibacumab and Obiltoxaximab, both of which are monoclonal antibodies. […] By mitigating toxin effects, antitoxins reduce systemic damage, prevent organ failure, and improve survival outcomes. Administering antitoxins early in the course of infection significantly enhances their effectiveness, as delayed use may allow toxins to irreversibly damage tissues and organs.

• #2 Anthrax – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/anthrax/diagnosis-treatment/drc-20356209

  Some cases of injection anthrax have been successfully treated with surgical removal of infected tissue. […] Although some cases of anthrax respond to antibiotics, advanced inhalation anthrax may not. By the later stages of the disease, the bacteria have often produced more toxins than drugs can eliminate. […] Along with antibiotics, people with anthrax may be treated with intensive supportive care including ventilators, fluids and medicines to tighten blood vessels and raise blood pressure (vasopressors).

• #2 Most effective anthrax treatment: Rapid diagnosis, antibiotics and lung drainage, VA-Stanford study finds | News Center

  https://med.stanford.edu/news/all-news/2006/02/most-effective-anthrax-treatment-rapid-diagnosis-antibiotics-and-lung-drainage-va-stanford-study-finds.html

  The study findings, published in the Feb. 21 issue of the Annals of Internal Medicine, underscore the importance of detecting anthrax early, educating medical personnel about its symptoms and treatment and ensuring efficient distribution systems that can deliver antibiotics to patients within hours of a bioterrorist attack. […] 'Even with our modern intensive care, once you’ve reached the advanced stage of this disease, you’re probably going to die. That’s why it’s crucial to start antibiotics within the first few days,’ said lead author Jon-Erik Holty, MD, a fellow in pulmonary and critical-care medicine at Stanford, who did the research during a fellowship in health services research at the VA Palo Alto Health Care System. […] Timely antibiotic treatment was the key to patients’ survival. When antibiotics were begun within two days of initial symptoms, approximately 20 percent of patients died. When treatment was begun at four days, mortality was about 58 percent, and at six days it was nearly 80 percent. Multi-drug regimens were found to be more effective than single-drug regimens. And among all the anthrax patients who survived, 80 percent had fluid drained from around their lungs, a procedure known as pleural fluid drainage.

• #2 Anthrax Treatment Options: Antibiotics, Antitoxins, And Supportive Care – Klarity Health Library

  https://my.klarity.health/anthrax-treatment-options-antibiotics-antitoxins-and-supportive-care/

  During anthrax treatment, medical professionals would offer supportive care by maintaining proper breathing, keeping fluid levels stable and avoiding shock. […] These interventions, combined with antibiotics and antitoxins, form a comprehensive approach to managing severe anthrax, significantly improving survival rates when administered promptly. Early action is critical to prevent irreversible damage. […] In conclusion, anthrax is a potentially fatal disease caused by Bacillus anthracis, requiring prompt treatment to prevent severe complications or death. Immediate treatment with antibiotics, administered orally or intravenously depending on severity, is crucial to halt bacterial growth and destruction. Antitoxins may also be employed to neutralize the toxins released by the bacteria, preventing symptom progression.

• #2 Anthrax Treatment Options: Antibiotics, Antitoxins, And Supportive Care – Klarity Health Library

  https://my.klarity.health/anthrax-treatment-options-antibiotics-antitoxins-and-supportive-care/

  For severe cases, advanced interventions like mechanical ventilation, hemodynamic support, and vasopressors are often required to stabilize the patient and prevent shock, particularly in inhalation anthrax. Early and effective medical intervention is key to managing anthrax infections and reducing fatality risks.

• #2 Rational corticosteroids administration and antibiotic treatment is key to managing cutaneous anthrax | BMC Infectious Diseases | Full Text

  https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09922-9

  Rational corticosteroids administration and antibiotic treatment is key to managing cutaneous anthrax. […] This research aims to explore the clinical presentations and phenotypic characteristics of cutaneous anthrax patients and evaluate the efficacy of various therapeutic approaches. […] Hormonal treatment markedly improved edema regression in patients (P0.002), highlighting its therapeutic value. […] The impact of various antibiotic treatments on disease progression differed significantly based on corticosteroids treatment status, with specific combinations showing more effectiveness in non-corticosteroids-treated patients. […] In cases where corticosteroids therapy is not utilized, employing piperacillin-tazobactam alone or in combination with quinolones effectively shortens the illness duration, suggesting a tailored approach to treatment can enhance patient outcomes.

• #2 Rational corticosteroids administration and antibiotic treatment is key to managing cutaneous anthrax | BMC Infectious Diseases | Full Text

  https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09922-9

  According to the recommendations of the World Health Organization (WHO), penicillin G is the preferred drug for treating anthrax. […] However, studies have shown that although Bacillus anthracis is highly susceptible to penicillin in laboratories, patients with high levels of the bacteria, such as those with inhalational anthrax, may develop penicillin resistance due to the production of beta-lactamase. […] Administration of corticosteroids might help reduce inflammatory edema in patients with severe toxemia symptoms or malignant edema. […] Our results indicated that administering corticosteroids to patients with moderate-to-severe oedema and severe systemic symptoms of infectious toxicity may accelerate the regression of edema at the site of infection, leading to a shorter hospital stay for the patient. […] When selecting an antibiotic regimen, the potential for -lactamase production and antibiotic resistance among clinical isolates should be considered. Piperacillin-tazobactam may be a viable option for initial treatment.

• #2 USAMRIID: Experimental Treatment with Enzyme Protects Mice from Lethal Anthrax Infection

  https://usamriid.health.mil/index.cfm/media/press_releases/2021/experimental_enzyme_treatment

  „This strategy renders B. anthracis susceptible to the innate immune responses and does not rely on antibiotics,” the authors concluded. „These findings suggest that enzyme-catalyzed removal of the capsule may be a potential therapeutic strategy for the treatment of multidrug-resistant anthrax and other bacterial infections.”

• #2 Anthrax – Symptoms & causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/anthrax/symptoms-causes/syc-20356203

  Signs and symptoms, which depend on how you’re infected, can include skin sores, vomiting and shock. Prompt treatment with antibiotics can cure most anthrax infections. Inhaled anthrax is more difficult to treat and can be fatal. […] To prevent infection after being exposed to anthrax spores, the Centers for Disease Control and Prevention recommends: A 60-day treatment with antibiotics ciprofloxacin, doxycycline and levofloxacin are approved for adults and children. […] In some cases, treatment with monoclonal antibodies raxibacumab and obiltoxaximab.

• #2 Anthrax Facts – MN Dept. of Health

  https://www.health.state.mn.us/diseases/anthrax/anthrax.html

  All forms of anthrax can be treated with antibiotics. It’s important to start treatment as soon as possible. It may be possible to prevent the disease if exposed people begin treatment soon enough. […] Early treatment with antibiotics, for people who may have been exposed to anthrax, is the best preventive measure.

• #2 Anthrax (Bacillus Anthracis) Causes, Symptoms, Diagnosis, Treatment

  https://www.medicinenet.com/anthrax/article.htm

  Individuals exposed to aerosolized spores (bioterrorism scares or attacks, for example) can participate in postexposure prevention of anthrax. Four antibiotics are recommended by the FDA: doxycycline (Doryx, Oracea, Monodox), ciprofloxacin, levofloxacin (Levaquin, Quixin, Iquix), and parenteral procaine penicillin G. In addition to these antibiotics, a three-dose series of anthrax vaccine should be started as soon as possible after exposure.

• #2 Most effective anthrax treatment: Rapid diagnosis, antibiotics and lung drainage, VA-Stanford study finds | News Center

  https://med.stanford.edu/news/all-news/2006/02/most-effective-anthrax-treatment-rapid-diagnosis-antibiotics-and-lung-drainage-va-stanford-study-finds.html

  Comparing the 2001 anthrax cases with all others previously reported, researchers found that the 2001 patients were more likely to have started antibiotics during the prodromal phase, to have used multi-drug treatments and to have received pleural fluid drainage. Likely as a result, these patients were less likely to have progressed to the fulminant phrase and to have died.

• #2 Most effective anthrax treatment: Rapid diagnosis, antibiotics and lung drainage, VA-Stanford study finds | News Center

  https://med.stanford.edu/news/all-news/2006/02/most-effective-anthrax-treatment-rapid-diagnosis-antibiotics-and-lung-drainage-va-stanford-study-finds.html

  When spores sent through the mail in 2001 caused 11 people to contract anthrax – ultimately killing five of them – infectious disease specialists noted that the death rate was substantially lower than the historical mortality rate, which approached 100 percent. […] But after completing the most comprehensive review of anthrax cases ever conducted, researchers at the Veterans Affairs Palo Alto Health Care System and Stanford University School of Medicine have found that what most likely saved lives from the various anthrax mailings in September 2001 was not advanced hospital care: It was rapid diagnosis and initiation of antibiotic treatment within the first few days of symptoms. […] The researchers found that once anthrax progresses to its advanced stage, which typically occurs four days after the first symptoms, patients are almost certain to die from it, even if they receive the best care modern medicine has to offer. They also found that drainage of fluid from around the lungs is a key procedure associated with anthrax patients’ survival.

• #2 What Is Anthrax and What Makes It Toxic to Humans?

  https://www.verywellhealth.com/anthrax-7482093

  If you’ve been exposed to anthrax, a healthcare provider can start treatment to help you fight off the infection. People exposed to anthrax can get an anthrax vaccine. They get three doses over four weeks. A healthcare provider will also give you antibiotics. […] If you think you’ve been exposed and are showing symptoms, a healthcare provider will try to determine how you may have been exposed. If you may have inhaled anthrax, they’ll order tests like chest X-rays or computed tomography (CT) scans. […] In all anthrax cases, a healthcare provider will give you medicine to treat the infection and reduce symptoms. […] Drugs used to treat anthrax infection include: Antibiotics to fight the bacteria, Antitoxins to stop the effects of the anthrax toxin. […] A healthcare provider will treat anthrax infection with antibiotics and antitoxins. With treatment, most people with anthrax will survive. Without treatment, anthrax infections can be deadly. […] The sooner you start treatment, the better your chances of recovery. Call a healthcare provider immediately if you think you may have been exposed to anthrax.

Zobacz więcej